12 Most Undervalued Long-Term Stocks to Buy Right Now

Page 3 of 11

​9. Elevance Health, Inc. (NYSE:ELV)

Forward P/E Ratio: 11.67

Number of Hedge Fund Holders: 67

​Elevance Health, Inc. (NYSE:ELV) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On October 21, Sarah James from Cantor Fitzgerald reiterated a Buy rating on Elevance Health, Inc. (NYSE:ELV) with a price target of $400.

​The firm maintains a cautious outlook on the 2026 Medicaid Environment, noting that the company has conservative elements in its 2026 earnings per share projections. In addition, the firm also believes that execution in Medicare Advantage, commercial business, and Carelon to be critical for the company’s performance in 2026 and 2027. They believe this is particularly important due to the Medicaid visibility becoming increasingly uncertain.

​Despite the cautious outlook, Cantor Fitzgerald believes that Elevance Health, Inc. (NYSE:ELV) will outperform expectations in the Medicare Advantage and Carelon segments.

​Elevance Health, Inc. (NYSE:ELV) is a health insurer in the United States offering various health plans and services.

Page 3 of 11